You just read:

Sorrento Therapeutics' Pain Subsidiary, SCILEX Pharmaceuticals, Announces Positive Data from Head to Head Adhesion Study with its Lead Product, ZTlido™

News provided by

Sorrento Therapeutics, Inc.

Jun 14, 2017, 09:00 ET